Yes Bank confident of Fortis Healthcare fetching good valuation

Published On 2018-04-30 05:00 GMT   |   Update On 2018-04-30 05:00 GMT

Mumbai: Terming Fortis Healthcare, which is on the block, as “a very attractive asset”, its single largest shareholder Yes Bank exuded the confidence of a sound resolution with a good valuation and thus help drive out of the management crisis plaguing one of the largest hospital chains in the county.


In February this year, Yes Bank, which was the largest lender to the hospital, had acquired a 17.31% stake by invoking nearly 9 crores pledged shares. Later in mid-March, it sold 2.17% of this bringing down its shareholding to 15.14% as of March 2018. Still, this makes the private lender the single largest shareholder in the New Delhi based hospital chain.


“Fortis is more than a performing asset for us,” Yes Bank managing director and chief executive Rana Kapoor said, adding, “I am very convinced that there will be a very good resolution.”


In the March quarter earnings announcement, the bank has last week said its over Rs1,500 crore exposure to Fortis is classified as “standard” in its books and that the bank has sufficient securities to cover the exposure.


Kapoor said he is not concerned about the quality of the bidders as Fortis is a prime healthcare asset in the country.


Four entities—the Manipal/TPG consortium, the KKR- backed Radiant Life Care, Malaysian major IHH Healthcare, and the family offices of the Munjals and Burmans — have given binding offers to the Fortis board.


“There are four-five world class bidders and the asset will be valued properly in the course of time,” Kapoor told reporters on the sidelines of an economic summit at the BSE.


He said the bank, as a shareholder, is not active in the valuation process of the hospital chain but has observed improvement in transparency and disclosures in the process.


“At the end of the day, it is going to be very competitive and fetch fantastic value for all investors, including minority shareholders,” he added.


On April 25, Renuka Ramnath, former head of ICICI Venture, resigned from the expert committee formed to evaluate the binding bids.

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News